Preferred Label : gavreto;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3333268/fr/gavreto-pralsetinib-cancer-bronchique
2022
false
false
false
France
French
evaluation of the transparency committee
advanced RET fusion-positive non-small cell lung cancer
Cancer
pralsetinib
registries
bronchial neoplasms
pralsetinib
gavreto
neoplasm, malignant
cancer
bronchus, nos

---
https://www.has-sante.fr/jcms/p_3326262/fr/gavreto-pralsetinib
https://www.has-sante.fr/jcms/p_3326214/fr/decision-n-2022-0081/dc/sem-du-17-mars-2022-du-college-de-la-haute-autorite-de-sante-portant-refus-de-la-demande-d-acces-precoce-de-la-specialite-gavreto
2022
false
false
false
France
treatment outcome
protein kinase inhibitors
RET Inhibitor
pralsetinib
carcinoma, non-small-cell lung
Advanced Lung Non-Small Cell Carcinoma
adult
RET Fusion Positive
gavreto
administration, oral
advanced RET fusion-positive non-small cell lung cancer
evaluation of the transparency committee
pralsetinib

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.